Evaluation of efficacy and safety of â??AHPL/AYTOP/2014Aâ?? in patients suffering from aphthous ulcers - an open label, randomized, multi-center, prospective, active controlled, parallel group, clinical study. - NI

Ari Healthcare Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated: November 24, 2021

Trial Snapshot

No summary available.

•1.Patients clinically diagnosed as aphthous ulcers
•2.Minor Mouth ulcers that have appeared less than a week prior to the enrollment
•3.Ulcers at accessible locations (labial, buccal mucosa, tongue preferably)
•4.Who can make all necessary visits and comply with the study procedures
•5.Subject willing to participate in clinical trial and who have read, understood and signed informed consent form

•1.Subjects Suffering from any other oral or dental disease or active skin disease.
•2.Patient under treatment of ulcers with systemic steroids, vitamins, antibiotics, antihistamines, oral Retinoids or immunomodulatory agents within three months before study entry.
•3.Patients having any major systemic diseases including genetic, endocrinal diseases, cancer, HIV, AIDS
•4.Known cases of hematological disorders, ulcerative colitis or Crohns disease.
•5.Patient who had a history of probable sensitivity to any mouthwash or toothpaste
•6.Patients having Anemia or known iron, folic acid, Vit. B12 deficiency
•7.Patient having addiction of alcohol or smoking or tobacco chewing
•8.Pregnant or lactating women
•9.Patients having known hypersensitivity to ingredients used in the study drugs

Sponsor

Ari Healthcare Pvt Ltd